July 21, 2021 View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease When: July 21, 2021, 12 p.m. ET Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular
July 15, 2021-July 26, 2021 VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Critical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Cons
July 16, 2021 View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development When: June 16, 2021, 12 p.m. ET Case Study: Modeling disease progression in polycystic kidney disease to inform tr
May 19, 2021 View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database When: May 19, 2021, 12 p.m. ET Example Disease: Polycystic kidney disease and kidney transplant Presenters: Jagde
C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop, June 15-16 TUCSON, Ariz., May 2
May 20, 2021 The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation
C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board TUCSON, Ariz., May 19, 2021 — Critical Path Institute today announced the appointment of Robert M. Califf, MD, MACC, head of Cli
ERA4TB Update NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted
C-Path Request for Proposal for External Communications Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, pu
C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates TUCSON, Ariz., May 12, 2021 — Criti